<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <policyArea>
      <name>Crime and Law Enforcement</name>
    </policyArea>
    <version>1.0.0</version>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 163, Number 187 (Wednesday, November 15, 2017)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. KATKO:H.R. 4408.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 1, with respect to the powerto ``lay and collect Taxes, Duties, Imposts, and Excises,''and to provide for the ``general Welfare of the UnitedStates.''[Page H9377]</pre>]]></constitutionalAuthorityStatementText>
    <titles>
      <item>
        <parentTitleType />
        <chamberCode />
        <titleType>Short Titles as Introduced</titleType>
        <chamberName />
        <title>Opioid Addiction Prevention Act of 2017</title>
      </item>
      <item>
        <parentTitleType />
        <chamberCode />
        <titleType>Official Title as Introduced</titleType>
        <chamberName />
        <title>To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.</title>
      </item>
      <item>
        <parentTitleType />
        <chamberCode />
        <titleType>Display Title</titleType>
        <chamberName />
        <title>Opioid Addiction Prevention Act of 2017</title>
      </item>
      <item>
        <parentTitleType />
        <chamberCode />
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <chamberName />
        <title>Opioid Addiction Prevention Act of 2017</title>
      </item>
    </titles>
    <title>Opioid Addiction Prevention Act of 2017</title>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Crime and Law Enforcement</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Drug, alcohol, tobacco use</name>
          </item>
          <item>
            <name>Health personnel</name>
          </item>
          <item>
            <name>Licensing and registrations</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <actions>
      <item>
        <actionDate>2017-12-13</actionDate>
        <committee>
          <systemCode>hsju08</systemCode>
          <name>Crime, Terrorism, Homeland Security, and Investigations Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2017-11-17</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionCode>H11100</actionCode>
        <actionDate>2017-11-15</actionDate>
        <committee>
          <systemCode>hsju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <links />
        <type>IntroReferral</type>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionCode>H11100</actionCode>
        <actionDate>2017-11-15</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <links />
        <type>IntroReferral</type>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionCode>Intro-H</actionCode>
        <actionDate>2017-11-15</actionDate>
        <committee />
        <links />
        <type>IntroReferral</type>
        <text>Introduced in House</text>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionCode>1000</actionCode>
        <actionDate>2017-11-15</actionDate>
        <committee />
        <links />
        <type>IntroReferral</type>
        <text>Introduced in House</text>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <actionTypeCounts>
        <placeholderTextForH>2</placeholderTextForH>
        <introducedInTheHouse>1</introducedInTheHouse>
        <billReferrals>2</billReferrals>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <actionByCounts>
        <houseOfRepresentatives>6</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <cosponsors>
      <item>
        <middleName>R.</middleName>
        <bioguideId>S001201</bioguideId>
        <party>D</party>
        <lastName>Suozzi</lastName>
        <state>NY</state>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Rep. Suozzi, Thomas R. [D-NY-3]</fullName>
        <identifiers>
          <gpoId />
          <lisID>2341</lisID>
          <bioguideId>S001201</bioguideId>
        </identifiers>
        <firstName>Thomas</firstName>
        <sponsorshipWithdrawnDate />
        <district>3</district>
        <sponsorshipDate>2017-11-15</sponsorshipDate>
      </item>
    </cosponsors>
    <laws />
    <sponsors>
      <item>
        <identifiers>
          <lisID>2264</lisID>
          <gpoId />
          <bioguideId>K000386</bioguideId>
        </identifiers>
        <bioguideId>K000386</bioguideId>
        <district>24</district>
        <lastName>Katko</lastName>
        <fullName>Rep. Katko, John [R-NY-24]</fullName>
        <middleName />
        <state>NY</state>
        <party>R</party>
        <firstName>John</firstName>
        <byRequestType />
      </item>
    </sponsors>
    <relatedBills>
      <item>
        <latestAction>
          <actionDate>2017-10-16</actionDate>
          <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <congress>115</congress>
        <type>HR</type>
        <number>3964</number>
        <latestTitle>Opioid Addiction Prevention Act of 2017</latestTitle>
      </item>
      <item>
        <latestAction>
          <actionDate>2018-01-09</actionDate>
          <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <congress>115</congress>
        <type>HR</type>
        <number>4482</number>
        <latestTitle>Opioid Abuse Deterrence, Research, and Recovery Act of 2017</latestTitle>
      </item>
      <item>
        <latestAction>
          <actionDate>2017-04-07</actionDate>
          <text>Read twice and referred to the Committee on the Judiciary.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Identical bill</type>
          </item>
        </relationshipDetails>
        <congress>115</congress>
        <type>S</type>
        <number>892</number>
        <latestTitle>Opioid Addiction Prevention Act of 2017</latestTitle>
      </item>
    </relatedBills>
    <amendments />
    <updateDate>2018-02-20T17:15:06Z</updateDate>
    <originChamber>House</originChamber>
    <recordedVotes />
    <calendarNumbers />
    <introducedDate>2017-11-15</introducedDate>
    <latestAction>
      <actionDate>2017-12-13</actionDate>
      <links />
      <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
    </latestAction>
    <billNumber>4408</billNumber>
    <notes />
    <createDate>2017-11-16T03:11:17Z</createDate>
    <cboCostEstimates />
    <billType>HR</billType>
    <committeeReports />
    <committees>
      <billCommittees>
        <item>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-11-15T15:01:45Z</date>
            </item>
          </activities>
          <chamber>House</chamber>
          <subcommittees>
            <item>
              <name>Crime, Terrorism, Homeland Security, and Investigations Subcommittee</name>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2017-12-13T22:31:40Z</date>
                </item>
              </activities>
              <systemCode>hsju08</systemCode>
            </item>
          </subcommittees>
          <systemCode>hsju00</systemCode>
          <name>Judiciary Committee</name>
          <type>Standing</type>
        </item>
        <item>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-11-15T15:01:40Z</date>
            </item>
          </activities>
          <chamber>House</chamber>
          <subcommittees>
            <item>
              <name>Health Subcommittee</name>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2017-11-17T17:40:39Z</date>
                </item>
              </activities>
              <systemCode>hsif14</systemCode>
            </item>
          </subcommittees>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
          <type>Standing</type>
        </item>
      </billCommittees>
    </committees>
    <congress>115</congress>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDesc>Introduced in House</actionDesc>
          <name>Introduced in House</name>
          <lastSummaryUpdateDate>2018-02-20T17:04:28Z</lastSummaryUpdateDate>
          <actionDate>2017-11-15</actionDate>
          <text><![CDATA[<p><b>Opioid Addiction Prevention Act of 2017</b></p> <p>This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law.</p> <p>An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit. </p>]]></text>
          <updateDate>2017-11-15T05:00:00Z</updateDate>
        </item>
      </billSummaries>
    </summaries>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

